Literature DB >> 31602335

The prognostic value of systemic immune-inflammation index (SII) in patients after radical operation for carcinoma of stomach in gastric cancer.

Qingshan Wang1, Dayong Zhu2.   

Abstract

BACKGROUND: The inflammatory reaction, which plays a key role in tumor microenvironment, is associated with the tumor development, progression and metastasis. We aim to estimate the potential prognostic value of systemic immune-inflammation index (SII) in patients after radical operation for carcinoma of stomach in gastric cancer.
METHODS: One hundred and eighty-two patients with gastric cancer who underwent radical operation for carcinoma of stomach from January 2009 to December 2012 were enrolled and divided into a low SII group (<600×109 cells/L) and a high SII group (SII ≥600×109 cells/L) based on the optimal cutoff value of SII. The clinicopathological features were analyzed and compared between the two groups of patients. We analyzed the disease-free survival (DFS) and the overall survival (OS) by Kaplan Meier survival curve and log-rank test. The prognostic factors were used to evaluate by univariate analysis, and the independent prognostic factors were assessed by using multivariate Cox proportional hazards regression model.
RESULTS: The median DFS and OS of all patients were 18.67 and 22.83 months, respectively. According to the univariate and multivariate analysis, the optimal cutoff value of SII had prognostic significance on DFS and OS. The median DFS and OS in low SII group were longer than those in high SII group (21.43 vs. 17.57 months, 28.03 vs. 18.30 months, respectively). The radical resection, type of surgery, metastatic lymph nodes ratio (MLNR), lymphocyte, SII, carcinoembryonic antigen (CEA) and Borrmann classification were the independent prognostic factors in gastric carcinoma. At the same time, the patients with MLNR in low SII group had longer DFS and OS than those with MLNR in high SII group, especially in patients with high MLNR.
CONCLUSIONS: SII may serve as a convenient, low-cost and noninvasive prognostic marker for patients after radical operation for carcinoma of stomach in gastric cancer. 2019 Journal of Gastrointestinal Oncology. All rights reserved.

Entities:  

Keywords:  Systemic immune-inflammation index (SII); gastric cancer; metastatic lymph nodes ratio (MLNR); prognostic marker; radical operation for carcinoma of stomach

Year:  2019        PMID: 31602335      PMCID: PMC6776812          DOI: 10.21037/jgo.2019.05.03

Source DB:  PubMed          Journal:  J Gastrointest Oncol        ISSN: 2078-6891


  22 in total

1.  Differences in gastric cancer survival between the U.S. and China.

Authors:  Vivian E Strong; Ai-Wen Wu; Luke V Selby; Mithat Gonen; Meier Hsu; Kyo Young Song; Cho Hyun Park; Daniel G Coit; Jia-Fu Ji; Murray F Brennan
Journal:  J Surg Oncol       Date:  2015-07-14       Impact factor: 3.454

2.  Platelets guide the formation of early metastatic niches.

Authors:  Myriam Labelle; Shahinoor Begum; Richard O Hynes
Journal:  Proc Natl Acad Sci U S A       Date:  2014-07-14       Impact factor: 11.205

Review 3.  Gastric cancer - clinical and epidemiological aspects.

Authors:  Marino Venerito; Alexander Link; Theodoros Rokkas; Peter Malfertheiner
Journal:  Helicobacter       Date:  2016-09       Impact factor: 5.753

4.  Cancer statistics, 2015.

Authors:  Rebecca L Siegel; Kimberly D Miller; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2015-01-05       Impact factor: 508.702

5.  Systemic therapy for advanced gastric cancer: a clinical practice guideline.

Authors:  M Mackenzie; K Spithoff; D Jonker
Journal:  Curr Oncol       Date:  2011-08       Impact factor: 3.677

Review 6.  Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion.

Authors:  Robert D Schreiber; Lloyd J Old; Mark J Smyth
Journal:  Science       Date:  2011-03-25       Impact factor: 47.728

7.  Systemic Immune-Inflammation Index Predicts the Clinical Outcome in Patients with mCRPC Treated with Abiraterone.

Authors:  Cristian Lolli; Orazio Caffo; Emanuela Scarpi; Michele Aieta; Vincenza Conteduca; Francesca Maines; Emanuela Bianchi; Francesco Massari; Antonello Veccia; Vincenzo E Chiuri; Gaetano Facchini; Ugo De Giorgi
Journal:  Front Pharmacol       Date:  2016-10-13       Impact factor: 5.810

8.  Comparison of tumor-infiltrating lymphocytes between primary and metastatic tumors in breast cancer patients.

Authors:  Rin Ogiya; Naoki Niikura; Nobue Kumaki; Giampaolo Bianchini; Shigehisa Kitano; Takayuki Iwamoto; Naoki Hayashi; Kozue Yokoyama; Risa Oshitanai; Mayako Terao; Toru Morioka; Banri Tsuda; Takuho Okamura; Yuki Saito; Yasuhiro Suzuki; Yutaka Tokuda
Journal:  Cancer Sci       Date:  2016-12       Impact factor: 6.716

9.  Systemic immune-inflammation index predicts the clinical outcome in patients with metastatic renal cell cancer treated with sunitinib.

Authors:  Cristian Lolli; Umberto Basso; Lisa Derosa; Emanuela Scarpi; Teodoro Sava; Matteo Santoni; Simon J Crabb; Francesco Massari; Michele Aieta; Vincenza Conteduca; Marco Maruzzo; Francesca La Russa; Matthew Wheater; Rossana Berardi; Luca Galli; Ugo De Giorgi
Journal:  Oncotarget       Date:  2016-08-23

10.  Monocyte to lymphocyte ratio predicts survival in patients with advanced gastric cancer undergoing neoadjuvant chemotherapy.

Authors:  Li Chen; Ying Hao; Lihua Zhu; Sen Li; Yanjiao Zuo; Yuxin Zhang; Hongjiang Song; Yingwei Xue
Journal:  Onco Targets Ther       Date:  2017-08-10       Impact factor: 4.147

View more
  14 in total

1.  Decreased albumin-to-alkaline phosphatase ratio predicted poor survival of resectable gastric cancer patients.

Authors:  Yan Wang; Feng Xiong; Jian Yang; Tingting Xia; Zhenyu Jia; Jiaqing Shen; Chunfang Xu; Jun Feng; Yongda Lu
Journal:  J Gastrointest Oncol       Date:  2021-08

2.  The relationship between pan-immune-inflammation value and survival outcomes in patients with metastatic renal cell carcinoma treated with nivolumab in the second line and beyond: a Turkish oncology group kidney cancer consortium (TKCC) study.

Authors:  Emre Yekedüz; Deniz Tural; İsmail Ertürk; Serdar Karakaya; Cihan Erol; Özlem Ercelep; Çağatay Arslan; Özlem Nuray Sever; Saadettin Kılıçkap; Nihan Şentürk Öztaş; Ahmet Küçükarda; Orçun Can; Berna Öksüzoğlu; Mehmet Ali Şendur; Nuri Karadurmuş; Yüksel Ürün
Journal:  J Cancer Res Clin Oncol       Date:  2022-05-26       Impact factor: 4.322

3.  Predictive Values of Preoperative Prognostic Nutritional Index and Systemic Immune-Inflammation Index for Long-Term Survival in High-Risk Non-Muscle-Invasive Bladder Cancer Patients: A Single-Centre Retrospective Study.

Authors:  Huifeng Bi; Zhenhua Shang; Chunsong Jia; Jiangtao Wu; Bo Cui; Qi Wang; Tongwen Ou
Journal:  Cancer Manag Res       Date:  2020-10-01       Impact factor: 3.989

4.  Prognostic Value of Pretreatment Systemic Immune-Inflammation Index in Gastric Cancer: A Meta-Analysis.

Authors:  Ye Qiu; Zongxin Zhang; Ying Chen
Journal:  Front Oncol       Date:  2021-03-11       Impact factor: 6.244

5.  Prognostic value of systemic immune-inflammatory index in survival outcome in gastric cancer: a meta-analysis.

Authors:  Shifeng Fu; Jin Yan; Yuyong Tan; Deliang Liu
Journal:  J Gastrointest Oncol       Date:  2021-04

6.  Systemic Immune-Inflammation Index Is Superior to Neutrophil to Lymphocyte Ratio in Prognostic Assessment of Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy.

Authors:  Cong Jiang; Yubo Lu; Shiyuan Zhang; Yuanxi Huang
Journal:  Biomed Res Int       Date:  2020-12-18       Impact factor: 3.411

7.  Elevated peripheral absolute monocyte count related to clinicopathological features and poor prognosis in solid tumors: Systematic review, meta-analysis, and meta-regression.

Authors:  Shu Wen; Nan Chen; Ying Hu; Litao Huang; Jin Peng; Meina Yang; Xiaoyang Shen; Yang Song; Liangzhi Xu
Journal:  Cancer Med       Date:  2021-02-16       Impact factor: 4.452

8.  Correlation analysis between preoperative systemic immune inflammation index and prognosis of patients after radical gastric cancer surgery: based on propensity score matching method.

Authors:  Xu Zhaojun; Chen Xiaobin; An Juan; Yuan Jiaqi; Jiang Shuyun; Liu Tao; Cai Baojia; Wang Cheng; Ma Xiaoming
Journal:  World J Surg Oncol       Date:  2022-01-03       Impact factor: 2.754

9.  Prognostic Significance of the Systemic Immune-Inflammation Index (SII) in Patients With Small Cell Lung Cancer: A Meta-Analysis.

Authors:  Yuting Zhou; Menglu Dai; Zongxin Zhang
Journal:  Front Oncol       Date:  2022-02-04       Impact factor: 6.244

10.  Predictive Effect of Systemic Immune-Inflammation Index Combined With Prognostic Nutrition Index Score on Efficacy and Prognosis of Neoadjuvant Intraperitoneal and Systemic Paclitaxel Combined With Apatinib Conversion Therapy in Gastric Cancer Patients With Positive Peritoneal Lavage Cytology: A Prospective Study.

Authors:  Ping'an Ding; Peigang Yang; Chenyu Sun; Yuan Tian; Honghai Guo; Yang Liu; Yong Li; Qun Zhao
Journal:  Front Oncol       Date:  2022-01-19       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.